Breaking News
Get 55% Off 0
🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?
Explore for Free
Close

Sbsa Itf Sygnia Health Innovation Global Equity Fund A (0P0001LCIR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.217 +0.010    +0.59%
21/11 - Delayed Data. Currency in ZAR
  • Morningstar Rating:
  • Total Assets: 857.34M
Type:  Fund
Market:  South Africa
Issuer:  Sygnia Collective Investments
ISIN:  ZAE000289039 
Asset Class:  Equity
SBSA ITF Sygnia Health Innovation Global Equity Fu 1.217 +0.010 +0.59%

0P0001LCIR Holdings

 
Comprehensive information about top holdings and Key Holding Information for the SBSA ITF Sygnia Health Innovation Global Equity Fu (0P0001LCIR) fund. Our SBSA ITF Sygnia Health Innovation Global Equity Fu portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Stocks 93.130 93.130 0.000
Bonds 1.760 1.760 0.000
Other 5.780 5.780 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 21.280 21.532
Price to Book 4.698 4.182
Price to Sales 2.075 2.430
Price to Cash Flow 18.495 17.266
Dividend Yield 1.710 1.312
5 Years Earnings Growth 10.993 13.330

Sector Allocation

Name  Net % Category Average
Healthcare 99.400 94.944
Basic Materials 0.250 1.660
Technology 0.140 2.800
Consumer Cyclical 0.130 9.073
Energy 0.070 0.070

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Africa & Middle East
  • Developed Markets

Top Holdings

Number of long holdings: 167

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Eli Lilly US5324571083 9.72 749.92 -0.46%
Fecrmbjsc4te0035zarusd20240918 - 8.12 - -
  Nedgroup Investments Corporate Money Market Fund C ZAE000167946 7.67 1.000 0%
  Novo Nordisk ADR US6701002056 4.55 102.63 -2.51%
  UnitedHealth US91324P1021 4.43 597.49 -0.50%
  Novo Nordisk ADR US6701002056 4.42 102.63 -2.51%
  J&J US4781601046 3.48 155.50 +1.56%
  Merck DE0006599905 3.26 139.80 +1.08%
  AbbVie US00287Y1091 2.95 171.73 +2.37%
Oxford Sciences Enterprises (Gbp) - 2.68 - -

Top Equity Funds by Sygnia Collective Investments

  Name Rating Total Assets YTD% 3Y% 10Y%
  Sygnia Skeleton Balanced 70 Fund A 7.63B 11.68 10.60 8.70
  Sygnia CPI + 4% Fund D 3.03B 11.65 10.10 8.00
  Sygnia CPI 4 Fund B 3.01B 12.11 10.70 8.81
  Sygnia 4th Ind Rev Global Eq A 2.95B 15.05 0.50 -
  Sygnia 4th Indust Rev Global Eq B 2.95B 14.46 0.77 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001LCIR Comments

Write your thoughts about Sbsa Itf Sygnia Health Innovation Global Equity Fund A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email